M YOCARDIAL ISCHEMIA Prepared by: Dr. Nehad Ahmed.

Slides:



Advertisements
Similar presentations
Blood Pressure.
Advertisements

 Cardiovascular System – Heart and Blood Vessels Topics in Human Pathophysiology Fall 2011 Gilead Drug Safety and Public Health.
Drugs to treat angina. I. Introduction Branching off the aorta are the coronary arteries.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 51 Drugs for Angina Pectoris.
CORONARY CIRCULATION DR. Eman El Eter.
Myocardial Ischemia Dr. Wael H. Mansy, MD Assistant Professor
Coronary Artery Disease. What is coronary artery disease? A narrowing of the coronary arteries that prevents adequate blood supply to the heart muscle.
ISCHEMIC HEART DISEASE. Coronary arteries  Left coronary artery supplies:  Left ventricle  Interventricular septum  Part of right ventricle.
M YOCARDIAL ISCHEMIA Prepared by: Dr. Nehad Ahmed.
 What is Coronary Heart Disease?  Who is at Risk for Coronary Heart Disease?  Signs and Symptoms of Coronary Heart Disease.  How Is Coronary Heart.
Ischemic heart disease
Ischemic Heart Diseases IHD
Assessment and management of patient with coronary artery disease
Risks & Prevention for Young Adults Cardiovascular Disease Kristen Hinners.
Elise Wood Stress Management. Narrowing of the walls of the arteries Excessive plaque build up Disrupts blood flow Potential cardiovascular complications.
Angina and MI.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Circulatory Disorders & Technologies Disorders: 1)Hypertension 2)Coronary Artery Disease - arteriosclerosis - atherosclerosis - angina - myocardial infarction.
Angina Pain and Related Cardiovascular Problems. What is Angina Pain?  A condition often referred to as “angina pectoris” --refers to thoracic pain originating.
Chapter 18 Agents that Dilate Blood Vessels. Copyright 2007 Thomson Delmar Learning, a division of Thomson Learning Inc. All rights reserved Coronary.
Chapter 13 HEART.
EMS 353. Lectures 6 Dr. Maha Khalid physiology of pharmacology cardiovascular system.
Gilead -Topics in Human Pathophysiology Fall 2010 Drug Safety and Public Health.
CORONARY CIRCULATION DR. Eman El Eter. Coronary Arteries The major vessels of the coronary circulation are: 1- left main coronary that divides into left.
1 ANGINA ANGINA MYOCARDIAL OXY. DEMAND >. OXY. SUPPLY. OXY. SUPPLY < SYMPTOMS – chest pain mostly relieved by taking rest, dyspnea, sweating, nausea..
Ischemic Heart Diseases
1.  Atherosclerosis is most common cause of coronary artery disease (CAD).  Atherosclerosis can affect one or all three major coronary arteries i.e.
Coronary Artery Disease Presented by: Marissa V. Dacumos Batch 17
Coronary Artery Disease A Presentation The Silent Killer.
3.10 – Circulatory Disorders and Technologies. Diagnosis and Treatment Electrocardiograph – an instrument that detects electrical signals of the heart.
2. Ischaemic Heart Disease.
The Incredible Heart APL3 Who sketched this?. Blood supply to the Heart Supplied to the heart muscle (myocardium) by the coronary arteries Supplied to.
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
Agents that Dilate Coronary Blood Vessels.  Coronary artery disease (CAD) results from atherosclerosis  Clinical symptoms caused by  narrowing of the.
BIMM118 Angina pectoris Medical term for chest pain or discomfort due to coronary heart disease. Typical angina pectoris (=“tight heart” is uncomfortable.
ANGINA PECTORIS Tb Tuberculosis Carl Matol, RN. ANGINA-to choke CLASSIC/STABLE ANGINA Due to insufficiency of O2 supply against myocardial demand Accumulated.
Antianginal drugs Angina pectoris is the severe chest pain that occurs when coronary blood flow is inadequate to supply the oxygen required by the heart.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm. Due to imbalance between myocardium oxygen requirement and.
Non-communicable Disease Coronary Heart Disease
Ischemic heart diseases Ischemia : it is inadequate supply of O2 to an organ or tissue (result from inadequate blood flow) insufficient to meet the organ’s.
Cardiovascular Monitoring Coronary Artery Disease.
Chapter 9 Heart. Review of Structure and Function The heart is divided into the systemic (left) and pulmonary (right) systems –The pulmonary system has.
Cardiovascular Disorders Cardiovascular disease (CVD) is the leading cause of death in Western countries. Cardiovascular disease (CVD) is the leading cause.
Drugs used in angina pectoris
Dr. Sohail Bashir Sulehria
 Heart disease remains the leading cause of morbidity and mortality in industrialized nations.  40% of all deaths in the U.S.A (nearly twice the number.
COMMON LIFESTYLE DISEASES: CHD EMS 355 By: Dr. Bushra Bilal.
Angina pectoris Sudden,severe,pressing chest pain starting substernal &radiate to left arm & neck. Due to imbalance between myocardium oxygen requirement.
Circulatory Disorders. Heart Attack A heart attack occurs when the blood supply to part of the heart muscle is severely reduced or stopped. The reduction.
ANGINA PECTORIS  By Charmaine Sta Ana. ETIOLOGY  Chest pain or discomfort due to decreased oxygen or lack of oxygen of the myocardium.
 Coronary artery disease (also called CAD) is the most common type of heart disease. It is also the leading cause of death for both men and women in.
Prepared by Miss Fatima Hirzallah.  Angina pectoris is a clinical syndrome usually characterized by episodes or paroxysms of pain or pressure in the.
Dr. Wael H. Mansy, MD Assistant Professor College of Pharmacy King Saud University Myocardial Ischemia.
CORONARY CIRCULATION.
Myocardial Infarction Angina Pectoris What is an MI?
Elsevier Inc. items and derived items © 2010 by Saunders, an imprint of Elsevier Inc.1 Drugs for Angina Pectoris.
Drugs for Angina Pectoris
PHARMACOLOGY OF ANTI-ANGINAL DRUGS (ID#580) Dr. Mariam Yousif Pharmacology & Toxicology Dept. November 17 th, 2014.
1 Angina Pectoris Prepared by : Ansam Sharef Ahmad Aswad.
Disease/Disorders of the Heart
Ischemic Heart Disease
CORONARY ARTERY DISEASE
21 Drugs For Angina Pectoris, Myocardial Infarction, And Cerebrovascular Accident.
Cardiovascular Disease Coronary Heart Disease
Angina Pectoris Prepared by : Ansam Sharef Ahmad Aswad.
Hypertension (High Blood Pressure)
Nursing Management: Patients With Coronary Vascular Disorders
Antianginal Drugs Ischemic Heart Disease Angina pectoris
Coronary Artery Disease and Acute Coronary Syndrome
Presentation transcript:

M YOCARDIAL ISCHEMIA Prepared by: Dr. Nehad Ahmed

S TUDY OBJECTIVES Understand the relationship between myocardial ischemia and angina. Distinguish among classic angina, unstable angina, variant angina and silent ischemia. Provide a rationale for pharmacologic and non- pharmacologic therapy in angina and myocardial ischemia. Explain the mechanism of action for the nitrates, β- blockers, calcium channel antagonists, aspirin and heparin in treatment of angina.

I NTRODUCTION Myocardial ischemia occurs when the blood flow demands of the heart exceed the blood supplied by the coronary arteries. The leading cause of myocardial ischemia is atherosclerosis or blockage of coronary arteries due to the accumulation of lipid plaques and/or thrombus

Under conditions of rest, myocardial oxygen supply and delivery of nutrients through the coronary arteries should match the metabolic requirements of the heart. When the metabolic needs of the heart increase, the coronary blood flow must increase accordingly.

With age and progressive occlusion of coronary arteries, smaller vessels may begin to carry a greater proportion of blood and provide an alternate means of perfusion for an area of myocardium. These collateral blood vessels may run parallel to the larger coronary arteries and be connected to other small coronary vessels by vascular connections called anastomoses.

Development of collateral circulation may reduce or delay the occurrence of symptoms from myocardial ischemia until the blockage is very progressed. The presence of extensively developed collateral circulation Might also explain why many older individuals often survive serious heart attacks when younger individuals, who have not yet developed collateral circulation, often do not.

M ANIFESTATIONS OF MYOCARDIAL ISCHEMIA Angina pectoris is the major symptom of myocardial ischemia. most commonly presents as pain, pressure or a burning sensation in the area of the sternum. Angina pectoris There are three types of angina pectoris: 1. Classic or exertional angina 2. Unstable angina 3. Variant angina

1. Classic or exertional angina - Pain is precipitated by increased workload on the heart. May be caused by exercise, emotions, stress and cold exposure. - Symptoms may remain “stable” for a number of years or progress in severity.

2. Unstable angina - Angina that occurs at rest. - Also referred to as “pre-infarct” angina since it is usually associated with extensive blockage of coronary arteries. - Coronary blood flow does not meet the needs of the heart even at rest. - Requires intensive treatment and evaluation.

3. Variant angina ( vasospastic angina, Prinzmetal’s angina) Caused by vasospasm of the coronary arteries. Usually associated with coronary artery disease but may result from excess sympathetic activity. Frequently occurs at night, at rest or during minimal exercise. May be precipitated by stress, cold exposure or smoking.

Silent ischemia is a particularly dangerous form of myocardial ischemia as there is a lack of clinical symptoms, i.e., ischemia without angina. Usually diagnosed by exercise stress testing or Holter monitoring

D IAGNOSIS OF M YOCARDIAL I SCHEMIA Electrocardiograph Holter monitoring — 24 ambulatory electrocardiograph Stress testing with electrocardiograph Nuclear imaging Cardiac catheterization

R ATIONALE FOR TREATMENT OF MYOCARDIAL ISCHEMIA Treatment of myocardial ischemia and the resulting angina can involve two strategies: 1. Increase coronary blood flow by dilating coronary arteries 2. Reduce cardiac workload by reducing heart rate and/or force of contraction

T REATMENT OF MYOCARDIAL ISCHEMIA The treatment regimen may include both nonpharmacologic and pharmacologic therapies. - Nonpharmacologic treatment physical activity Avoidance of stress (emotional, physiologic, cold) Reduction of risk factors for ischemic heart disease (hyperlipidemia, obesity, hypertension, diabetes, smoking, etc.)

P HARMACOLOGIC TREATMENT Organic nitrates Dilate coronary arteries and increase myocardial blood flow. Dilate peripheral arteries and reduce β afterload Dilate peripheral veins and reduce preload

Adrenergic blockers Block myocardial β. -adrenergic receptors. Reduce heart rate and cardiac output (reduced myocardial work- load and oxygen demand).

calcium channel blockers Block calcium channels in vascular smooth muscle. Dilate coronary arteries and increase myocardial blood flow. Dilate peripheral arteries and reduce afterload.

Aspirin, heparin Prevent platelet aggregation. Use for prophylaxis of blood clots particularly in unstable angina.

S URGICAL TREATMENT Coronary angioplasty Uses a balloon catheter to open occluded blood vessels Usually performed under local anesthetic 5% mortality, high rate of vessel re- occlusion Use of metal “stents” in opened vessel reduces rate of occlusion

Coronary artery bypass graft Revascularization procedure in which a blood vessel is taken from elsewhere in the body and surgically sutured around a blocked coronary artery May involve multiple (one to five) blood vessels Re-occlusion of transplanted vessel is possible

K EY TERMS Ischemia — Inadequate blood flow to a tissue or part of the body. Hypoxia — Deficiency of oxygen in tissues. Preload —The load on the heart at the end of diastole. Afterload —The force that the contracting heart must generate to eject blood.

Thank You